Hans Keirstead
Chairman & CEO,
AiVita Biomedical, Inc.
United States
Dr. Hans Keirstead is an internationally recognized stem cell expert and entrepreneur in regenerative medicine. He has pioneered therapies for cancer, immune disorders, motor neuron diseases, spinal cord injury, retinal diseases, immune disorders, age-related immune decline, and infectious diseases. Currently, he holds board positions in several leading biotechs including AIVITA Biomedical, Immunis Inc., and the Human Immune Project. His international media recognition includes being listed as one of Discover Magazine’s top 100 scientists, and highlights in Newsweek, WIRED, The New York Times, TIME Magazine and Science. His scientific accomplishments have been covered by 60 Minutes, PBS, and ABC News. Some of Dr. Keirstead’s notable awards include the “Top 20 Canadians” Award by the Consul General of Canada, “Most Innovative in Immune Deficiency Research,” by Corporate LiveWire, “Best Immune Deficit Treatment Development” by Global Health and Pharma, OCBJ’s “Innovator of the Year,” NIH Solowey award for noted national researcher of the year, recognition as a world thought leader at the Seven Wonderer's event by Beakerhead, and the Cameron Award for the best PhD in the country. Dr. Keirstead received his Ph.D. in neuroscience from the University of British Columbia, Canada, and pursued his postdoctoral research at the University of Cambridge, England.
Suffix
PhD
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}